DNA Oyjn verkkoinfrastruktuuriliiketoiminnan jrjestely toteutui
| DNA Stock | USD 11.11 0.09 0.80% |
About 56% of Ginkgo Bioworks' investor base is looking to short. The analysis of the overall investor sentiment regarding Ginkgo Bioworks Holdings suggests that many traders are alarmed. The current market sentiment, together with Ginkgo Bioworks' historical and current headlines, can help investors time the market. In addition, many technical investors use Ginkgo Bioworks Holdings stock news signals to limit their universe of possible portfolio assets.
Ginkgo |
DNA OYJ PRSSITIEDOTE 7.1.2025 KLO 17.00 DNA Oyjn Suomen verkkoinfrastruktuuriliiketoiminta, jota harjoitetaan yhtin tytryhtin DNA Tower Finland Oyn...
Read at globenewswire.com
 |
Ginkgo Bioworks Fundamental Analysis
We analyze Ginkgo Bioworks' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ginkgo Bioworks using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ginkgo Bioworks based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Ginkgo Bioworks is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Ginkgo Bioworks Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ginkgo Bioworks stock to make a market-neutral strategy. Peer analysis of Ginkgo Bioworks could also be used in its relative valuation, which is a method of valuing Ginkgo Bioworks by comparing valuation metrics with similar companies.
Peers
Ginkgo Bioworks Related Equities
| HEPA | Hepion Pharmaceuticals | 8.20 |
| ||
| OCEA | Ocean Biomedical | 9.46 |
| ||
| ELEV | Elevation Oncology | 9.64 |
| ||
| ENVB | Enveric Biosciences | 16.00 |
|
Complementary Tools for Ginkgo Stock analysis
When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |